[go: up one dir, main page]

FR2974300B1 - Utilisation d'une combinaison d'un carotenoide, d'un phytoestrogene et de la vitamine c pour la prevention et/ou le traitement de desordres pigmentaires - Google Patents

Utilisation d'une combinaison d'un carotenoide, d'un phytoestrogene et de la vitamine c pour la prevention et/ou le traitement de desordres pigmentaires

Info

Publication number
FR2974300B1
FR2974300B1 FR1153392A FR1153392A FR2974300B1 FR 2974300 B1 FR2974300 B1 FR 2974300B1 FR 1153392 A FR1153392 A FR 1153392A FR 1153392 A FR1153392 A FR 1153392A FR 2974300 B1 FR2974300 B1 FR 2974300B1
Authority
FR
France
Prior art keywords
carotenoid
vitamin
phytoestrogen
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1153392A
Other languages
English (en)
Other versions
FR2974300A1 (fr
Inventor
Nathalie Piccardi
Carole Bru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutricos Technologies SNC
Original Assignee
Laboratoires Inneov SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1153392A priority Critical patent/FR2974300B1/fr
Application filed by Laboratoires Inneov SNC filed Critical Laboratoires Inneov SNC
Priority to EP12720634.0A priority patent/EP2699218B1/fr
Priority to BR112013026933-2A priority patent/BR112013026933B1/pt
Priority to PCT/IB2012/051924 priority patent/WO2012143856A1/fr
Priority to CN201280019226.5A priority patent/CN103702654A/zh
Priority to ARP120101322 priority patent/AR086106A1/es
Priority to TW101114025A priority patent/TWI581806B/zh
Publication of FR2974300A1 publication Critical patent/FR2974300A1/fr
Application granted granted Critical
Publication of FR2974300B1 publication Critical patent/FR2974300B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR1153392A 2011-04-19 2011-04-19 Utilisation d'une combinaison d'un carotenoide, d'un phytoestrogene et de la vitamine c pour la prevention et/ou le traitement de desordres pigmentaires Expired - Fee Related FR2974300B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR1153392A FR2974300B1 (fr) 2011-04-19 2011-04-19 Utilisation d'une combinaison d'un carotenoide, d'un phytoestrogene et de la vitamine c pour la prevention et/ou le traitement de desordres pigmentaires
BR112013026933-2A BR112013026933B1 (pt) 2011-04-19 2012-04-17 Usos de uma combinação
PCT/IB2012/051924 WO2012143856A1 (fr) 2011-04-19 2012-04-17 Utilisation d'une combinaison de caroténoïde, de phytoestrogène et de vitamine c pour la prévention et/ou le traitement de troubles de la pigmentation
CN201280019226.5A CN103702654A (zh) 2011-04-19 2012-04-17 类胡萝卜素、植物雌激素和维生素c的组合用于预防和/或治疗色素沉着症的用途
EP12720634.0A EP2699218B1 (fr) 2011-04-19 2012-04-17 Utilisation d'une combinaison d'un caroténoïde, d'un phytoestrogène et de la vitamine c pour la prévention et/ou le traitement de désordres pigmentaires
ARP120101322 AR086106A1 (es) 2011-04-19 2012-04-18 Uso de una combinacion de un carotenoide, un fitoestrogeno y vitamina c como un agente activo, para el embellecimiento de la piel
TW101114025A TWI581806B (zh) 2011-04-19 2012-04-19 使用類胡蘿蔔素、植物雌激素及維生素ｃ之組合作為活性劑供美化皮膚之用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1153392A FR2974300B1 (fr) 2011-04-19 2011-04-19 Utilisation d'une combinaison d'un carotenoide, d'un phytoestrogene et de la vitamine c pour la prevention et/ou le traitement de desordres pigmentaires

Publications (2)

Publication Number Publication Date
FR2974300A1 FR2974300A1 (fr) 2012-10-26
FR2974300B1 true FR2974300B1 (fr) 2013-05-10

Family

ID=44654233

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1153392A Expired - Fee Related FR2974300B1 (fr) 2011-04-19 2011-04-19 Utilisation d'une combinaison d'un carotenoide, d'un phytoestrogene et de la vitamine c pour la prevention et/ou le traitement de desordres pigmentaires

Country Status (5)

Country Link
EP (1) EP2699218B1 (fr)
CN (1) CN103702654A (fr)
BR (1) BR112013026933B1 (fr)
FR (1) FR2974300B1 (fr)
WO (1) WO2012143856A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102015375B1 (ko) * 2013-08-14 2019-08-28 주식회사 엘지생활건강 항산화 및 피부 미백용 조성물
CN103948672B (zh) * 2014-05-05 2020-06-12 南宁富莱欣生物科技有限公司 一种包衣片剂及其生产方法
CN105055293A (zh) * 2015-08-17 2015-11-18 彭小兰 含有番茄红素的延缓衰老面膜及其制备方法
KR102767886B1 (ko) * 2020-03-19 2025-02-18 주식회사 엘지생활건강 카칼라이드를 포함하는 조성물
CN114414809B (zh) * 2022-03-28 2022-06-21 中元伯瑞生物科技(珠海横琴)有限公司 用于诊断尘肺病的生物标志物的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2940964B2 (ja) 1989-12-15 1999-08-25 株式会社資生堂 テストステロン―５α―レダクターゼ阻害剤
US5637561A (en) 1993-10-12 1997-06-10 Protein Technologies International, Inc. Aglucone isoflavone enriched vegetable protein whey, whey protein, and process for producing
BR9407792A (pt) 1993-10-12 1997-03-18 Protein Tech Int Processo para produção de um extrato enriquecido com isoflavona de aglucona de um material de proteina vegetal extrato enriquecido com isoflavona de aglucona isolado de proteina enriquecido com isoflavona de aglucona isolado de proteina vegetal e processo para recuperação de pelo menos 50% de uma isoflavona de um material de proteina vegetal
DE4432947C2 (de) 1994-09-16 1998-04-09 New Standard Gmbh Mittel zur Behandlung der Haut und seine Verwendung
US5679806A (en) 1995-02-24 1997-10-21 Hauser, Inc. Process for the isolation and purification of isoflavones
JPH08283136A (ja) 1995-04-12 1996-10-29 Kao Corp しわ形成抑制剤
US5554519A (en) 1995-08-07 1996-09-10 Fermalogic, Inc. Process of preparing genistein
US5670632A (en) 1996-01-18 1997-09-23 Acds Technologies, Ltd. Process for obtaining an isoflavone concentrate from a soybean extract
US5821361A (en) 1996-06-11 1998-10-13 Protein Technologies International, Inc. Recovery of isoflavones from soy molasses
FR2749758B1 (fr) 1996-06-12 1998-08-07 Oenobiol Sa Lab Composition a activite bronzante et photoprotectrice et ses applications esthetiques
ES2262658T3 (es) 2000-05-30 2006-12-01 Societe Des Produits Nestle S.A. Composicion primaria que contiene un compuesto bioactivo lipofilo.
FR2815861B1 (fr) * 2000-10-26 2003-02-28 Oreal Utilisation de l'association d'au moins un carotenoide et d'au moins un isoflavonoide pour traiter les signes cutanes du vieillissement
FR2815859B1 (fr) 2000-10-26 2003-02-28 Oreal Utilisation de l'association d'au moins un carotenoide a activite provitaminique a et d'au moins un carotenoide sans activite provitaminique a pour traiter les signes du vieillissement
FR2859908A1 (fr) * 2003-09-24 2005-03-25 Oreal Composition comprenant au moins un inhibiteur de metalloproteinase et au moins un agent myorelaxant ou relaxant
EA201000641A1 (ru) * 2007-10-17 2010-10-29 Юнилевер Н.В. Заключенные в капсулу с покрытием омега-3 жирные кислоты и/или омега-6 жирные кислоты и/или их эфиры
DE102008009799B4 (de) * 2008-02-18 2017-07-20 Beiersdorf Ag Verwendung von 3-(4-Hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-propan-1-on gegen Hyperpigmentierung

Also Published As

Publication number Publication date
FR2974300A1 (fr) 2012-10-26
BR112013026933A2 (pt) 2017-07-25
CN103702654A (zh) 2014-04-02
BR112013026933B1 (pt) 2018-02-06
WO2012143856A1 (fr) 2012-10-26
EP2699218B1 (fr) 2018-10-17
EP2699218A1 (fr) 2014-02-26

Similar Documents

Publication Publication Date Title
NZ722326A (en) Tricyclic compounds as anticancer agents
UA103915C2 (ru) Твердая лекарственная форма, которая содержит линаглиптин и ингибитор sglt2, и ее применение
EA200802090A1 (ru) Новое применение соединений и комбинаций соединений для улучшения внешнего вида
BR112015014458A2 (pt) derivados de manose para o tratamento de infecções bacterianas
MX2016003582A (es) Compuesto inhibidor de las actividades de las cinasas btk y/o jak3.
EA201591403A1 (ru) Спиролактамные модуляторы рецептора nmda и их применение
UA111588C2 (uk) Композиція інгібітора jak для місцевого застосування
EA201590655A1 (ru) Комбинация лахинимода и придопидина для лечения нейродегенеративных нарушений
MA47356B1 (fr) Dérivés d'isochromène utiles en tant qu'inhibiteurs des phosphoinositide 3-kinases
EP2709453A4 (fr) Utilisation de composés thiazolides pour la prévention et le traitement d'infections virales, du cancer et de maladies causées par des infections intracellulaires
EA201591404A1 (ru) Спиролактамные модуляторы рецептора nmda и их применение
BR112013003847A2 (pt) métodos de tratar a deterioração cognitiva moderada (mci) e os distúrbios relacionados
MA38810A1 (fr) Inhibiteurs de rorc2 méthodes d'utilisation associées
PH12016502353A1 (en) Pharmaceutical composition
BR112013015877A2 (pt) composto, uso de um composto, métodos de prevenção. tratamento, melhora ou profilaxia de distúrbios fisiológicos ou doenças, e de tratamento ou melhora de indicações cosméticas, e, composição farmacêutica.
TW201613577A (en) Pharmaceutical combinations
FR2974300B1 (fr) Utilisation d'une combinaison d'un carotenoide, d'un phytoestrogene et de la vitamine c pour la prevention et/ou le traitement de desordres pigmentaires
EP2878305A4 (fr) Composition pharmaceutique pour la prévention ou le traitement de maladies médiées par stat-3, contenant un extrait ou une fraction de salvia plebeia r. br. en tant que principe actif
WO2014071168A3 (fr) Administration d'inhibiteurs de la signalisation tgfbêta, dérivés de benzothiazépine ou combinaisons de ceux-ci pour améliorer la fonction musculaire chez des patients cancéreux
MA39447B1 (fr) Pirlindole ou ses sels pharmaceutiquement acceptables pour une utilisation en médecine
UA119446C2 (uk) 1,2,4-ТРИАЗОЛО[4,3-а]ПІРИДИНОВІ СПОЛУКИ ТА ЇХ ЗАСТОСУВАННЯ ЯК ПОЗИТИВНИХ АЛОСТЕРИЧНИХ МОДУЛЯТОРІВ РЕЦЕПТОРІВ MGLUR2
HRP20161447T1 (hr) Pripravak koji sadrži ekstrakt zelenog čaja i ekstrakt nara, namijenjen upotrebi u sprječavanju ili usporavanju napredovanja raka prostate
MX2013012038A (es) Combinacion de carotenoide, fitoestrogeno y vitamina c para la humectacion de la piel.
MA39448A1 (fr) (r)-pirlindole et ses sels pharmaceutiquement acceptables destinés à un usage médical
EA201390055A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОПИРАЗОЛО[3,4-b]АЗЕПИНА И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ МЕТАБОТРОПНЫХ ГЛУТАМАТНЫХ РЕЦЕПТОРОВ

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 5

CA Change of address

Effective date: 20160118

CD Change of name or company name

Owner name: NUTRICOS TECHNOLOGIES, FR

Effective date: 20160118

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 10

ST Notification of lapse

Effective date: 20211205